ןורתפה .סדייאה תלחמל ןורתפ שי ,םלועה ףוס הניא סדייאה תלחמ וארקת .תונטק אל תוחלצה שיו .םלועה תונידממ הברהב םשויצ
.תירבעל םגרותי םישדוח המכ ךות תילגנאב רמאמה.םכמצעב וטילחתו treatment of HIV infection and AIDS-associated diseases.
ARMENICUMS is a highly promising drug for against wide range of bacterial and viral diseases.
in animals and has been shown to be safe and effective ARMENICUMS has been tested CD4(T) cell count, and greatly improves quality of life.
reduces viral load (amount of HIV in the blood), increases ARMENICUMS ARMENICUMS means more benefit with less side effects.
Address to audience
"Armenicum" even more popular for the first beneficiaries.
which did not benefit from traditional approaches, make with the range of side effect and group of patients, a broader patient’s population. Available therapies is under the number of trials to make it available for so long expected for infected with different viruses, gets the blood by direct infusion. Alternative therapy, safely controls the process of Iodine elimination, when effect of Iodine is delivered through the substance, which harm for animals and human beings. Well-known antiviral thought before, amount of Iodine in the body without any niche for a new substance which brings an enormous, as was occupy an empty niche on shelters of drug stores. It is a "Armenicums", it is already obvious, that it will forever the "alien species", viruses. Regardless of future need in the human beings challenge to successfully fight against company accomplished an important step towards It is a pleasure to state that "Armenicums" pharmaceutical
drug "Armenicums", which is our challenge and our pride.
active substances we are mostly focused on an antiviral working in different directions with different problems that men still face today. But nevertheless, arsenal of several alternative approaches for important we are young enterprise, we are already rich with our Although, "Armenicum". We offer you to argue but not just deny.
experiment. We see essential benefits for patients taking the experience we gathered, when being in an alternative We are ready to bring our voice as argument and share stage of transparent and open relationship with the world. a fist stage of self-doubts and right now we are on a We have certainly overcome us in order to overcome all barriers and reach the truth.
Your attitude is very important for
Levon Gevorkian President
The Head of Armenicums Project, The world Armenicums project
referred to as acquired immunodeficiency syndrome (AIDS).
complications. The later clinically manifested stage is with HIV-causative agent and leading to a number of fatal state developing in the result of the contamination is a slowly but inevitably progressive immunodeficiency HIV-infection
than 95% of which were registered in developing countries.
were registered daily in the world, at that, more year approximately 14000 new cases of HIV-infection people have died. During the first months of the current has been registered in more than 200 countries, 25million are women. Initiating unprecedented epidemic, the disease among them 2.7 million are children and 17.6 million million (according to unofficial data – 150 million) quantity of children and adults with HIV/AIDS will be 40 of the UNAIDS experts by the end of 2003, the statistical within the last two decades. According to the assessments one country, one profession and even the medicine in whole HIV-infection pandemy has left the borders of
children were among the registered HIV-infected patients.
cases of HIV-infection were registered. 97 females and 8 in Armenia, too. As per the 31st of August 2006, 415 There is a serious risk in AIDS spreading
does not suppose immune system normal functioning.
of associated/opportunistic pathologies, and unfortunately with the inhibition of virus replication, causative agents VL decrease up to non-detectable level is not accompanied classification of therapeutic failure types. At last, HIV level isn’t always possible. Moreover, there is a load (VL) parameters. To reach and keep VL non-detectable Therapy monitoring first of all is based on the viral drugs, administered orally, and last indefinitely long. include combination therapy with several antiretroviral Current HIV-infection treatment regimens
among anti-HIV drugs efficacy criteria by all means.
count, and patient’s quality of life must be present clinical trials conduction, viral load, CD4+-T lymphocytes In compliance with the contemporary rules of
and RNA- containing viruses, including HIV1 and HIV 2.
non-specific activity towards a wide spectrum of DNA- study of a new antiviral drug which displays pronounced in the Republic of Armenia with the aim of elaboration and of Drugs and Medical Technologies Agency, was established supervisor of “Armenicums” project, Director the head of academician Emil S. Gabrielyan, the scientific project, a creative scientific-research group at Doctor of NAS of the RA, Head of “Armenicums” In 1994 by sponsorship of Mr. Levon Gevorgyan, Honorary
and displaying pronounced activity towards HIV-infection.
of antiviral, antibacterial and immune-modulating activity for intravenous infusion, possessing a wide spectrum was elaborated and declared as a concentrate In 1998 the drug “Armenicums”
and production of cytokines by lymphocytes and monocytes.
on the activation processes, differentiation, apoptosis prolongation of action systemic immune-modulating effect low toxicity, controlled diffusion of active components, complex of lithium-iodine-organic polymers provides the antiviral and fungicidal properties completely. The polymers, both keeps and strengthens its anticeptic, Iodine, available in the molecules of bio- and synthetic the spheres of iodine solutions usage are limited. and cysticidal activity. However, due to its high toxicity Iodine exhibits bactericidal, fungicidal, protozoacidal polymers complex in water solution of electrolytes. drug “Armenicums” is an iodine-lithium-organic The
drugs are not effective towards viruses.
as far as all antibiotics and chemical-therapeutic activity of iodine-polymers must be specially mentioned the wide spectrum of iodine as an antiseptic. An antiviral pathogenic yeasts and viruses, at that maintaining active towards Gram-positive and Gram-negative microbes, is a very valuable property of iodine-polymers. They are A wide spectrum of biological action
as well, confirmed the declared properties of the drug.
since 1998 and not only in Armenia but in other countries on more than 400 HIV-infected patients being conducted of Armenia on 4 kinds of animals, and clinical trials drug “Armenicums”, conducted in the Republic Pre-clinical studies of the
effect on HIV-patients’ health status are made:
trials, below-listed main conclusions of Armenicum In the result of clinical health distress, quality of life, health transition.
cognitive function, pain, mental health, energy/fatigue, health, physical function, role function, social function, quality of life in the following dimensions: overall 1. Armenicums significantly improves 2. It decreases HIV-1 viral load.
in T4-lymphocytes count and integral surrogate markers.
3. It improves the immune status, evaluated by changes parapsoriasis, eczema, recurrent herpetic infection.
and allergic dermatitis, neurodermitis, psoriasis, warts, condilomatosis, pityriasis versicolor, seborrheic vulgaris, folliculitis, ostiofolliculitis, piodermitis, regression of some dermatological diseases, such as acne 4. It leads to and sleep disorders in patients with encephalopathy.
gait, as well as decreases severity of radicular syndrome sensible sequence, movement coordination, including the 5. It improves memory, including professional speech, its in human organism which is one of its main properties.
drug “Armenicums” does not cause resistance 6. The small bandage room, fitness center in the hospital.
rooms, a big injection hall, a room for intensive therapy, virologic tests. There are 27 well-furnished wards, 2 Lux biochemical, serological, bacteriological, immunologic and equipment makes possible to perform all clinical, of contemporary medicine. The up-to-date laboratory and medical center which meets all the latest demands was founded in December 1999. It is a unique scientific The new clinic of Armenicums Project
is one of the best in CIS countries.
staff. The clinical center CJSC “Armenicums” clinic is provided with multi-language and professional to maintain stable temperature during whole year. The heating and air-conditioning system makes it possible The central
the materials of 6 international conferences/symposiums.
of definite properties of the drug are published in Several articles and abstracts concerning the discussion interest but of applied interest as well. English which is not only of great scientific-theoretical studies of the drug, were published in Russian and scientific articles devoted to experimental and clinical 2 issues of
for treatment of serious and life-threatening diseases.
and in EMEA of the European Union, for the drugs, directed out in FDA (Food and Drug Administration) of the USA “Guidelines of Accelerated Approval”, worked in the Republic of Armenia in accordance with the The drug “Armenicums” is registered